Nadia M T Roodenrijs
Overview
Explore the profile of Nadia M T Roodenrijs including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
275
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hofman Z, Roodenrijs N, Nikiphorou E, Kent A, Nagy G, Welsing P, et al.
Rheumatology (Oxford)
. 2024 Oct;
64(1):65-73.
PMID: 39383505
Difficult-to-treat RA (D2T RA) is an area of high unmet need. The prevalence reported in the first D2T RA cohort studies ranged from 5.5% to 27.5%. Key to the definition...
2.
Roodenrijs N, Welsing P, van Roon J, Schoneveld J, van der Goes M, Nagy G, et al.
Rheumatology (Oxford)
. 2022 Mar;
61(9):3552-3566.
PMID: 35238332
Management of RA patients has significantly improved over the past decades. However, a substantial proportion of patients is difficult-to-treat (D2T), remaining symptomatic after failing biological and/or targeted synthetic DMARDs. Multiple...
3.
Nagy G, Roodenrijs N, Welsing P, Kedves M, Hamar A, van der Goes M, et al.
Ann Rheum Dis
. 2021 Aug;
81(1):20-33.
PMID: 34407926
Objective: To develop evidence-based European Alliance of Associations for Rheumatology (EULAR) points to consider (PtCs) for the management of difficult-to-treat rheumatoid arthritis (D2T RA). Methods: An EULAR Task Force was...
4.
Messelink M, Roodenrijs N, van Es B, Hulsbergen-Veelken C, Jong S, Overmars L, et al.
Arthritis Res Ther
. 2021 Jul;
23(1):184.
PMID: 34238346
Background: The new concept of difficult-to-treat rheumatoid arthritis (D2T RA) refers to RA patients who remain symptomatic after several lines of treatment, resulting in a high patient and economic burden....
5.
Roodenrijs N, van der Goes M, Welsing P, van Oorschot E, Nikiphorou E, Nijhof N, et al.
Rheumatology (Oxford)
. 2021 Feb;
60(11):5105-5116.
PMID: 33560301
Objectives: Treatment non-adherence is more frequent among difficult-to-treat (D2T) than among non-D2T RA patients. Perceptions of non-adherence may differ. We aimed to thematically structure and prioritize barriers to (i.e. causes...
6.
Roodenrijs N, Kedves M, Hamar A, Nagy G, van Laar J, van der Heijde D, et al.
RMD Open
. 2021 Jan;
7(1).
PMID: 33514671
Objectives: To summarise the evidence on diagnostic issues in difficult-to-treat rheumatoid arthritis (D2T RA) informing the EULAR recommendations for the management of D2T RA. Methods: A systematic literature review (SLR)...
7.
Roodenrijs N, Welsing P, van der Goes M, Tekstra J, Lafeber F, Jacobs J, et al.
Rheumatology (Oxford)
. 2021 Jan;
60(10):4681-4690.
PMID: 33502493
Objectives: To determine the impact of difficult-to-treat rheumatoid arthritis (D2T RA) on (costs related to) healthcare utilization, other resource use and work productivity. Methods: Data regarding healthcare utilization, other resource...
8.
Roodenrijs N, Hamar A, Kedves M, Nagy G, van Laar J, van der Heijde D, et al.
RMD Open
. 2021 Jan;
7(1).
PMID: 33419871
Objectives: To summarise, by a systematic literature review (SLR), the evidence regarding pharmacological and non-pharmacological therapeutic strategies in difficult-to-treat rheumatoid arthritis (D2T RA), informing the EULAR recommendations for the management...
9.
Roodenrijs N, van der Goes M, Welsing P, Tekstra J, Lafeber F, Jacobs J, et al.
Rheumatology (Oxford)
. 2020 Dec;
60(8):3778-3788.
PMID: 33331946
Objectives: Treatment of difficult-to-treat (D2T) RA patients is generally based on trial-and-error and can be challenging due to a myriad of contributing factors. We aimed to identify risk factors at...
10.
Roodenrijs N, Welsing P, van der Goes M, Jacobs J, van der Heijde D, van Laar J, et al.
Ann Rheum Dis
. 2020 Dec;
82(3):e56.
PMID: 33277239
No abstract available.